References
1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018;68:394-424.
2. Instituto Nacional de Câncer. Estimativa 2020: incidência de câncer no Brasil. Rio de Janeiro INCA; 2020.
3. Rowe DE, Carroll RJ, Day CL Jr. Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. Implications for treatment modality selection.J Am Acad Dermatol. 1992;26(6):976-990.
4. Karia SP, Han J, Schmults CD. Cutaneous Squamous cell carcinoma: estimated incidence of disease, nodal metastasis, and deaths from disease in the united states. JAMA Dermatol. 2013;3:957-966.
5. Goh RY, Bova R, Fogarty GB. Cutaneous squamous cell carcinoma metastatic to parotid - analysis of prognostic factors and treatment outcome. World J Surg Oncol 2012;25(10):117.
6. Stratigos AJ, Garbe C, Dessinioti C, et al. European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 1. epidemiology, diagnostics and prevention. Eur J Cancer 2020;26(20):30018-30016.
7. Jennings L, Schmults CD. Management of High-Risk Cutaneous Squamous Cell Carcinoma. J Clin Aesthet Dermatol. 2010;3(4):39-48.
8. Stratigos AJ, Garbe C, Dessinioti C, et al. European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 2. Treatment. Eur J Cancer 2020;26(20):30019-30018.
9. Cassarino DS, Derienzo DP, Barr RJ. Cutaneous squamous cell carcinoma: a comprehensive clinicopathologic classification. Part one.J CutanPathol. 2006;33:191-206.
10. Swenny L, Zimmerman T, Carroll WR, Schmalbach CE, Day KE, Rosenthal EL. Head and neck cutaneous squamous cell carcinoma requiring parotidectomy: prognostic indicators and treatment selection.Otolaryngol Head Neck Surg. 2014;150:610-617.
11. Vauterin TJ, Veness MJ, Morgan GJ, Poulsen MG, O’Brien CJ. Patterns of lymph node spread of cutaneous squamous cell carcinoma of the head and neck. Head Neck. 2006;28(9):785-791.
12. Bobin C, Ingrand P, Dréno B, Rio E, Malard O, Espitalier F. Prognostic factors for parotid metastasis of cutaneous squamous cell carcinoma of the head and neck. European Annals of Otorhinolaryngology, Head and Neck Diseases,. 2018;135(2):99-103.
13. Gurney B, Newlands C. Management of regional metastatic disease in head and neck cutaneous malignancy. 1. Cutaneous squamous cell carcinoma. Br J Oral Maxillofac Surg. 2014;52:294-300.
14. Veness MJ, Palme CE, Morgan GJ. High-risk cutaneous squamous cell carcinoma of the head and neck: results from 266 treated patients with metastatic lymph node disease. Cancer 2006;106(11):2389-2396.
15. Lee S, Kim GE, Park CS, et al. Primary squamous cell carcinoma of the parotid gland. Am J Otolaryngol. 2001;22:400-406.
16. Ch’ng S, Maitra A, Allison RS, et al. Parotid and cervical nodal status predict prognosis for patients with head and neck metastatic cutaneous squamous cell carcinoma. J Surg Oncol2008;98(2):101-105.
17. Brantsch KD, Meisner C, Schönfisch B, et al. Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospec-tive study. Lancet Oncol. 2008;9:713-720.
18. O’Brien CJ, McNeil EB, McMahon JD, Pathak I, Lauer CS. Incidence of cervical node involvement in metastatic cutaneous malignancy involving the parotid gland. Head Neck. 2001;23:744-748.
19. Forest VI, Clark JJ, Veness MJ, Milross C. N1S3: a revised staging system for head and neck cutaneous squamous cell carcinoma with lymph node metastases: results of 2 Australian Cancer Centers. Cancer.2010;116(5):1298-1304.
20. Amin MB, Edge S, Greene F, et al. AJCC Cancer Staging Manual (8th edition). Springer International Publishing: American Joint Commission on Cancer; 2017; 2017.
21. Thom JJ, Moore EJ, Price DL, Kasperbauer JL, Starkman SJ, Olsen KD. The Role of Total Parotidectomy for Metastatic Cutaneous Squamous Cell Carcinoma and Malignant Melanoma. JAMA Otolaryngol Head Neck Surg. 2014;140(6):548-554.
22. Wei-Chin Chang, Chun-Shu Lin, Cheng-Yu Yang, Chih-Kung Lin, Yuan-Wu Chen. Lymph node density as a prognostic predictor in patients with betel nut-related oral squamous cell carcinoma. Clin Oral Invest.2018;22:1513-1521.
23. Agha RA, Borrelli MR, Farwana R, et al. Statement: Updating Consensus Preferred Reporting Of CasE Series in Surgery (PROCESS) Guidelines. International Journal of Surgery. 2018;60:279-282.
24. Agha RA, Borrelli MR, Vella-Baldacchino M, Thavayogan R, Orgill DP, STROCSS Group. The STROCSS statement: Strengthening the Reporting of Cohort Studies in Surgery. Int J Surg 2017;46:198-202.
25. Ogrinc G, Davies L, Goodman D, Batalden P, Davidoff F, Stevens D. SQUIRE 2.0 (Standards for QUality Improvement Reporting Excellence): revised publication guidelines from a detailed consensus process.BMJ Quality & Safety. 2016;25:986-992.
26. National Comprehensive Cancer Network (NCCN). National Comprehensive Cancer Network (NCCN). NCCN Clinical Practice Guidelines in Oncology. Squamous Cell Skin Cancer. Version 1.2020. National Comprehensive Cancer Network. https://www.nccn.org/professionals/physician_gls/pdf/squamous.pdf. Published 2019. Accessed2020.
27. Keohane SG, Proby CM, Newlands C, Motley RJ, Nasr I, Mohd Mustapa MF. The new 8th edition of TNM staging and its implications for skin cancer: a review by the British Association of Dermatologists and the Royal College of Pathologists, U.K. Br J Dermatol.2018;179(4):824-828.
28. Batsakis JG. Surgical excision margins: a pathologist’s perspective.Advances in Anatomic Pathology. 1999;6(3):140-148.
29. O’Brien CJ, McNeil EB, McMahon JD, Pathak I, Lauer CS, Jackson MA. Significance of clinical stage, extent of surgery, and pathologic findings in metastatic cutaneous squamous carcinoma of the parotid gland. . Head Neck. 2012;24(5):417-422.
30. Myers LL, Ahn C. Cutaneous squamous cell carcinoma metastasis to the parotid region lymph nodes. Laryngoscope 2019;129(7):1579-1586.
31. Košec A, Svetina L, Lukšić I. Significance of clinical stage, extent of surgery and outcome in cutaneous squamous cell carcinoma of the head and neck. International Journal of Oral and Maxillofacial Surgery. 2013;42(1):82-88.
32. Newlands C, Currie R, Memon A, Whitaker S, Woolford T. Non-melanoma skin cancer: United Kingdom National Multidisciplinary Guidelines.J Laryngol Otol 2016;130(S125-S132).
33. Creighton F, Lin A, Leavitt E, Lin D, Deschler D, Emerick K. Factors affecting survival and locoregional control in head and neck cSCCA with nodal metastasis. Laryngoscope 2018;128(8):1881-1886.
34. Bachar G, Mizrachi A, Rabinovics N, et al. Prognostic factors in metastatic cutaneous squamous cell carcinoma of the head and neck.Ear Nose Throat J. 2016;95(10-11):E32-E36.
35. Coombs AC, Butler A, Allison R. Metastatic cutaneous squamous cell carcinoma of the parotid gland: prognostic factors. J Laryngol Otol 2018;132(3):264-269.
36. Skulsky SL, O’Sullivan B, McArdle O, et al. Review of high-risk features of cutaneous squamous cell carcinoma and discrepancies between the American Joint Committee on Cancer and NCCN Clinical Practice Guidelines In Oncology. Head Neck 2017;39(3):578-594.
37. Varra V, Woody NM, Reddy C, et al. Suboptimal Outcomes in Cutaneous Squamous Cell Cancer of the Head and Neck with Nodal Metastases.Anticancer Res 2018;38(10):5825-5830.
38. Sullivan CB, Andresen NS, Kendell N, Al-Qurayshi Z, Pagedar NA. Survival Outcomes for Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck. Ann Otol Rhinol Laryngol. 2019;128(10):949-955.
39. Sweeny L, Zimmerman T, Carroll WR, Schmalbach CE, Day KE, Rosenthal EL. Head and neck cutaneous squamous cell carcinoma requiring parotidectomy: prognostic indicators and treatment selection.Otolaryngol Head Neck Surg. 2014;150(4):610-617.
40. Makki FM, Mendez AI, Taylor SM, et al. Prognostic factors for metastatic cutaneous squamous cell carcinoma of the parotid. J Otolaryngol Head Neck Surg. 2013;5(42):14-22.
41. Iyer NG, Clark JR, Murali R, Gao K, O’Brien CJ. Outcomes following parotidectomy for metastatic squamous cell carcinoma with microscopic residual disease: implications for facial nerve preservation. Head Neck 2009;31(1):21-27.
42. O’Brien CJ, McNeil EB, McMahon JD, Pathak I, Lauer CS, Jackson MA. Significance of clinical stage, extent of surgery, and pathologic findings in metastatic cutaneous squamous carcinoma of the parotid gland. Head Neck 2002;24(5):417-422.
43. D’Souza J, Clark J. Management of the neck in metastatic cutaneous squamous cell carcinoma of the head and neck. Curr Opin Otolaryngol Head Neck Surg 2011;19(2):99-105.
44. Creighton F, Lin A, Leavitt E, Lin D, Deschler D, Emerick K. Factors affecting survival and locoregional control in head and neck cSCCA with nodal metastasis. Laryngoscope. 2018;128(8):1881-1886.
45. Audet N, Palme CE, Gullane PJ, et al. Cutaneous metastatic squamous cell carcinoma to the parotid gland: analysis and outcome. Head Neck. 2004;26(8):727-732.
46. Andruchow JL, Veness MJ, Morgan GJ, et al. Implications for clinical staging of metastatic cutaneous squamous carcinoma of the head and neck based on a multicenter study of treatment outcomes. Cancer.2006;106(5):1078-1083.
47. Speight PM, Barrett AW. Salivary gland tumor. Oral dis.2002;9:229-240.
48. Palme CE, O’Brien CJ, Venesse CJ, McNeil EB, Bron LP, GJ M. Extent of Parotid Disease Influences Outcome in Patients With Metastatic Cutaneous Squamous Cell Carcinoma. Arch Otolaryngol Head Neck Surg. 2003;129(7):750-753.
49. Skulsky SL, O’Sullivan B, McArdle O, et al. Review of high-risk features of cutaneous squamous cell carcinoma and discrepancies between the American Joint Committee on Cancer and NCCN Clinical Practice Guidelines In Oncology. Head Neck. 2017;39(3):578-594.